Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis

BACKGROUND: We assessed the cost-effectiveness of adding a quadrivalent (6/11/16/18) human papillomavirus (HPV) vaccine to the current screening programme in the UK compared to screening alone. METHODS: A Markov model of the natural history of HPV infection incorporating screening and vaccination wa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kulasingam, Shalini L, Benard, Steve, Barnabas, Ruanne V, Largeron, Nathalie, Myers, Evan R
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2008
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2290741/
https://ncbi.nlm.nih.gov/pubmed/18279515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1478-7547-6-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados